These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases. Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670 [TBL] [Abstract][Full Text] [Related]
8. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262 [TBL] [Abstract][Full Text] [Related]
11. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus. Chappuis BB; Müller-Hermelink HK Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977 [TBL] [Abstract][Full Text] [Related]
12. Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders. Shabani M; Nichols KE; Rezaei N Crit Rev Oncol Hematol; 2016 Dec; 108():109-127. PubMed ID: 27931829 [TBL] [Abstract][Full Text] [Related]
13. Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China. Dilmurat D; Wang X; Gao L; Tian J; Ai J; Zhang L; Liu M; Feng G; Zeng Y; Wang R; Xie Z Ital J Pediatr; 2024 Jul; 50(1):125. PubMed ID: 38956696 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors. Eminger LA; Hall LD; Hesterman KS; Heymann WR J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918 [TBL] [Abstract][Full Text] [Related]
15. Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142. Sakakibara A; Kohno K; Ishikawa E; Suzuki Y; Shimada S; Eladl AE; Elsayed AA; Daroontum T; Satou A; Takahara T; Ohashi A; Takahashi E; Kato S; Nakamura S; Asano N Pathol Int; 2020 Aug; 70(8):481-492. PubMed ID: 32367595 [TBL] [Abstract][Full Text] [Related]
16. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency. Bienemann K; Borkhardt A; Klapper W; Oschlies I Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736 [TBL] [Abstract][Full Text] [Related]
18. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Shimoyama Y; Yamamoto K; Asano N; Oyama T; Kinoshita T; Nakamura S Cancer Sci; 2008 Jun; 99(6):1085-91. PubMed ID: 18429953 [TBL] [Abstract][Full Text] [Related]
19. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature. Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204 [TBL] [Abstract][Full Text] [Related]
20. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]